Articles

Vlaar, A. P. J.; Kulik, W.; Nieuwland, R.; Peters, C. P.; Tool, A. T. J.; van Bruggen, R.; Juffermans, N. P.; de Korte, D. Accumulation of bioactive lipids during storage of blood products is not cell but plasma derived and temperature dependent. Transfusion 2011, 51 (11), 2358-2366.

Vlaar APJ, Kulik W, Nieuwland R, et al. Accumulation of bioactive lipids during storage of blood products is not cell but plasma derived and temperature dependent. Transfusion. 2011;51(11):2358-2366.

A. P. J. Vlaar et al., “Accumulation of bioactive lipids during storage of blood products is not cell but plasma derived and temperature dependent,” Transfusion, vol. 51, no. 11, pp. 2358-2366, Nov. 2011.

Vlaar APJ, Kulik W, Nieuwland R, Peters CP, Tool ATJ, van Bruggen R, et al. Accumulation of bioactive lipids during storage of blood products is not cell but plasma derived and temperature dependent. Transfusion. 2011 Nov;51(11):2358-2366.

Rank, A.; Nieuwland, R.; Toth, B.; Pihusch, V.; Delker, R.; Hiller, E.; Kolb, H.; Pihusch, R. Microparticles for diagnosis of graf-versus-host disease after allogeneic stem transplantation. Transplantation 2011, 92 (2), 244-250.

Rank A, Nieuwland R, Toth B, et al. Microparticles for diagnosis of graf-versus-host disease after allogeneic stem transplantation. Transplantation. 2011;92(2):244-250.

A. Rank et al., “Microparticles for diagnosis of graf-versus-host disease after allogeneic stem transplantation,” Transplantation, vol. 92, no. 2, pp. 244-250, Jul. 2011.

Rank A, Nieuwland R, Toth B, Pihusch V, Delker R, Hiller E, et al. Microparticles for diagnosis of graf-versus-host disease after allogeneic stem transplantation. Transplantation. 2011 Jul;92(2):244-250.

Rank, A.; Nieuwland, R.; Delker, R.; Pihusch, V.; Wilkowski, R.; Toth, B.; Kolb, H.; Pihusch, R. Surveillance of megakaryocytic function by measurement of CD61-exposing microparticles in allogeneic hematopoietic stem cell recipients. Clin. Transplant. 2011, 25 (3), E233-E242.

Rank A, Nieuwland R, Delker R, et al. Surveillance of megakaryocytic function by measurement of CD61-exposing microparticles in allogeneic hematopoietic stem cell recipients. Clin Transplant. 2011;25(3):E233-E242.

A. Rank et al., “Surveillance of megakaryocytic function by measurement of CD61-exposing microparticles in allogeneic hematopoietic stem cell recipients,” Clin. Transplant., vol. 25, no. 3, pp. E233-E242, May. 2011.

Rank A, Nieuwland R, Delker R, Pihusch V, Wilkowski R, Toth B, et al. Surveillance of megakaryocytic function by measurement of CD61-exposing microparticles in allogeneic hematopoietic stem cell recipients. Clin Transplant. 2011 May;25(3):E233-E242.

Juffermans, N. P.; Prins, D. J.; Vlaar, A. P. J.; Nieuwland, R.; Binnekade, J. M. Transfusion-related risk of secondary bacterial infections in sepsis patients: a retrospective cohort study. Int. Congr. Ser. 2011, 35 (4), 355-359.

Juffermans NP, Prins DJ, Vlaar APJ, Nieuwland R, Binnekade JM. Transfusion-related risk of secondary bacterial infections in sepsis patients: a retrospective cohort study. Int Congr Ser. 2011;35(4):355-359.

N. P. Juffermans, D. J. Prins, A. P. J. Vlaar, R. Nieuwland, and J. M. Binnekade, “Transfusion-related risk of secondary bacterial infections in sepsis patients: a retrospective cohort study,” Int. Congr. Ser., vol. 35, no. 4, pp. 355-359, Apr. 2011.

Juffermans NP, Prins DJ, Vlaar APJ, Nieuwland R, Binnekade JM. Transfusion-related risk of secondary bacterial infections in sepsis patients: a retrospective cohort study. Int Congr Ser. 2011 Apr;35(4):355-359.

Ayers, L.; Kohler, M.; Harrison, P.; Sargent, I.; Dragovic, R.; Schaap, M.; Nieuwland, R.; Brooks, S. A.; Ferry, B. Measurement of circulating cell-derived microparticles by flow cytometry: Sources of variability within the assay. Thromb. Res. 2011, 127 (4), 370-377.

Ayers L, Kohler M, Harrison P, et al. Measurement of circulating cell-derived microparticles by flow cytometry: Sources of variability within the assay. Thromb Res. 2011;127(4):370-377.

L. Ayers et al., “Measurement of circulating cell-derived microparticles by flow cytometry: Sources of variability within the assay,” Thromb. Res., vol. 127, no. 4, pp. 370-377, Apr. 2011.

Ayers L, Kohler M, Harrison P, Sargent I, Dragovic R, Schaap M, et al. Measurement of circulating cell-derived microparticles by flow cytometry: Sources of variability within the assay. Thromb Res. 2011 Apr;127(4):370-377.

van der Post, J. A. M.; Lok, C. A. R.; Boer, K.; Sturk, A.; Sargent, I. L.; Nieuwland, R. The functions of microparticles in pre-eclampsia. Semin. Thromb. Hemost. 2011, 37 (02), 146-152.

van der Post JAM, Lok CAR, Boer K, Sturk A, Sargent IL, Nieuwland R. The functions of microparticles in pre-eclampsia. Semin Thromb Hemost. 2011;37(02):146-152.

J. A. M. van der Post, C. A. R. Lok, K. Boer, A. Sturk, I. L. Sargent, and R. Nieuwland, “The functions of microparticles in pre-eclampsia,” Semin. Thromb. Hemost., vol. 37, no. 02, pp. 146-152, Mar. 2011.

van der Post JAM, Lok CAR, Boer K, Sturk A, Sargent IL, Nieuwland R. The functions of microparticles in pre-eclampsia. Semin Thromb Hemost. 2011 Mar;37(02):146-152.

Rank, A.; Nieuwland, R.; Liebhardt, S.; Iberer, M.; Grützner, S.; Toth, B.; Pihusch, R. Apheresis platelet concentrates contain platelet-derived and endothelial cell-derived microparticles. Vox Sang. 2011, 100 (2), 179-186.

Rank A, Nieuwland R, Liebhardt S, et al. Apheresis platelet concentrates contain platelet-derived and endothelial cell-derived microparticles. Vox Sang. 2011;100(2):179-186.

A. Rank et al., “Apheresis platelet concentrates contain platelet-derived and endothelial cell-derived microparticles,” Vox Sang., vol. 100, no. 2, pp. 179-186, Feb. 2011.

Rank A, Nieuwland R, Liebhardt S, Iberer M, Grützner S, Toth B, et al. Apheresis platelet concentrates contain platelet-derived and endothelial cell-derived microparticles. Vox Sang. 2011 Feb;100(2):179-186.

Tushuizen, M. E.; Diamant, M.; Sturk, A.; Nieuwland, R. Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe?. Arterioscl. Throm. Vas. 2011, 31 (1), 4-9.

Tushuizen ME, Diamant M, Sturk A, Nieuwland R. Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe?. Arterioscl Throm Vas. 2011;31(1):4-9.

M. E. Tushuizen, M. Diamant, A. Sturk, and R. Nieuwland, “Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe?,” Arterioscl. Throm. Vas., vol. 31, no. 1, pp. 4-9, Jan. 2011.

Tushuizen ME, Diamant M, Sturk A, Nieuwland R. Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe?. Arterioscl Throm Vas. 2011 Jan;31(1):4-9.

Rank, A.; Nieuwland, R.; Crispin, A.; Grützner, S.; Iberer, M.; Toth, B.; Pihusch, R. Clearance of platelet microparticles in vivo. Platelets 2011, 22 (2), 111-116.

Rank A, Nieuwland R, Crispin A, et al. Clearance of platelet microparticles in vivo. Platelets. 2011;22(2):111-116.

A. Rank et al., “Clearance of platelet microparticles in vivo,” Platelets, vol. 22, no. 2, pp. 111-116, Jan. 2011.

Rank A, Nieuwland R, Crispin A, Grützner S, Iberer M, Toth B, et al. Clearance of platelet microparticles in vivo. Platelets. 2011 Jan;22(2):111-116.

Lok, C. A.; van der Post, J. A.; Sturk, A.; Sargent, I. L.; Nieuwland, R. The functions of microparticles in preeclampsia. Pregnancy Hypertens. 2011, 1 (1), 59-65.

Lok CA, van der Post JA, Sturk A, Sargent IL, Nieuwland R. The functions of microparticles in preeclampsia. Pregnancy Hypertens. 2011;1(1):59-65.

C. A. Lok, J. A. van der Post, A. Sturk, I. L. Sargent, and R. Nieuwland, “The functions of microparticles in preeclampsia,” Pregnancy Hypertens., vol. 1, no. 1, pp. 59-65, Jan. 2011.

Lok CA, van der Post JA, Sturk A, Sargent IL, Nieuwland R. The functions of microparticles in preeclampsia. Pregnancy Hypertens. 2011 Jan;1(1):59-65.

Biró, É.; van den Goor, J. M.; de Mol, B. d. M.; Schaap, M. C.; Ko, L.; Sturk, A.; Hack, C.; Nieuwland, R. Complement activation on the surface of cell-derived microparticles during cardiac surgery with cardiopulmonary bypass - is retransfusion of pericardial blood harmful?. Perfusion 2011, 26 (1), 21-29.

Biró É, van den Goor JM, de Mol BdM, et al. Complement activation on the surface of cell-derived microparticles during cardiac surgery with cardiopulmonary bypass - is retransfusion of pericardial blood harmful?. Perfusion. 2011;26(1):21-29.

É. Biró et al., “Complement activation on the surface of cell-derived microparticles during cardiac surgery with cardiopulmonary bypass - is retransfusion of pericardial blood harmful?,” Perfusion, vol. 26, no. 1, pp. 21-29, Jan. 2011.

Biró É, van den Goor JM, de Mol BdM, Schaap MC, Ko L, Sturk A, et al. Complement activation on the surface of cell-derived microparticles during cardiac surgery with cardiopulmonary bypass - is retransfusion of pericardial blood harmful?. Perfusion. 2011 Jan;26(1):21-29.

Berckmans, R. J.; Sturk, A.; van Tienen, L. M.; Schaap, M. C.; Nieuwland, R. Cell-derived vesicles exposing coagulant tissue factor in saliva. Blood 2011, 117 (11), 3172-3180.

Berckmans RJ, Sturk A, van Tienen LM, Schaap MC, Nieuwland R. Cell-derived vesicles exposing coagulant tissue factor in saliva. Blood. 2011;117(11):3172-3180.

R. J. Berckmans, A. Sturk, L. M. van Tienen, M. C. Schaap, and R. Nieuwland, “Cell-derived vesicles exposing coagulant tissue factor in saliva,” Blood, vol. 117, no. 11, pp. 3172-3180, Jan. 2011.

Berckmans RJ, Sturk A, van Tienen LM, Schaap MC, Nieuwland R. Cell-derived vesicles exposing coagulant tissue factor in saliva. Blood. 2011 Jan;117(11):3172-3180.

Nieuwland, R.; van der Post, J. A. M.; Lok, C. A. R.; Kenter, G. G.; Sturk, A. Microparticles and Exosomes in Gynecologic Neoplasias. Semin. Thromb. Hemost. 2010, 36 (8), 925-929.

Nieuwland R, van der Post JAM, Lok CAR, Kenter GG, Sturk A. Microparticles and Exosomes in Gynecologic Neoplasias. Semin Thromb Hemost. 2010;36(8):925-929.

R. Nieuwland, J. A. M. van der Post, C. A. R. Lok, G. G. Kenter, and A. Sturk, “Microparticles and Exosomes in Gynecologic Neoplasias,” Semin. Thromb. Hemost., vol. 36, no. 8, pp. 925-929, Nov. 2010.

Nieuwland R, van der Post JAM, Lok CAR, Kenter GG, Sturk A. Microparticles and Exosomes in Gynecologic Neoplasias. Semin Thromb Hemost. 2010 Nov;36(8):925-929.

Rank, A.; Nieuwland, R.; Delker, R.; Köhler, A.; Toth, B.; Pihusch, V.; Wilkowski, R.; Pihusch, R. Cellular origin of platelet-derived microparticles in vivo. Thromb. Res. 2010, 126 (4), e255-e259.

Rank A, Nieuwland R, Delker R, et al. Cellular origin of platelet-derived microparticles in vivo. Thromb Res. 2010;126(4):e255-e259.

A. Rank et al., “Cellular origin of platelet-derived microparticles in vivo,” Thromb. Res., vol. 126, no. 4, pp. e255-e259, Oct. 2010.

Rank A, Nieuwland R, Delker R, Köhler A, Toth B, Pihusch V, et al. Cellular origin of platelet-derived microparticles in vivo. Thromb Res. 2010 Oct;126(4):e255-e259.

Vlaar, A. P. J.; Hofstra, J. J.; Kulik, W.; van Lenthe, H.; Nieuwland, R.; Schultz, M. J.; Levi, M. M.; Roelofs, J. J. T. H.; Tool, A. T. J.; de Korte, D.; et al. Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model. Blood 2010, 116 (8), 1360-1368.

Vlaar APJ, Hofstra JJ, Kulik W, et al. Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model. Blood. 2010;116(8):1360-1368.

A. P. J. Vlaar et al., “Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model,” Blood, vol. 116, no. 8, pp. 1360-1368, Aug. 2010.

Vlaar APJ, Hofstra JJ, Kulik W, van Lenthe H, Nieuwland R, Schultz MJ, et al. Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model. Blood. 2010 Aug;116(8):1360-1368.

Vlaar, A. P. J.; Hofstra, J. J.; Levi, M.; Kulik, W.; Nieuwland, R.; Tool, A. T. J.; Schultz, M. J.; de Korte, D.; Juffermans, N. P. Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a “two-hit” in vivo syngeneic transfusion model. Anesthesiology 2010, 113 (1), 92-103.

Vlaar APJ, Hofstra JJ, Levi M, et al. Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a “two-hit” in vivo syngeneic transfusion model. Anesthesiology. 2010;113(1):92-103.

A. P. J. Vlaar et al., “Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a “two-hit” in vivo syngeneic transfusion model,” Anesthesiology, vol. 113, no. 1, pp. 92-103, Jul. 2010.

Vlaar APJ, Hofstra JJ, Levi M, Kulik W, Nieuwland R, Tool ATJ, et al. Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a “two-hit” in vivo syngeneic transfusion model. Anesthesiology. 2010 Jul;113(1):92-103.

Van Eijk, I. C.; Tushuizen, M. E.; Sturk, A.; Dijkmans, B. A. C.; Boers, M.; Voskuyl, A. E.; Diamant, M.; Wolbink, G. J.; Nieuwland, R.; Nurmohamed, M. T. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis. Ann. Rheum. Dis. 2010, 69 (7), 1378-1382.

Van Eijk IC, Tushuizen ME, Sturk A, et al. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis. Ann Rheum Dis. 2010;69(7):1378-1382.

I. C. Van Eijk et al., “Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis,” Ann. Rheum. Dis., vol. 69, no. 7, pp. 1378-1382, Jul. 2010.

Van Eijk IC, Tushuizen ME, Sturk A, Dijkmans BAC, Boers M, Voskuyl AE, et al. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis. Ann Rheum Dis. 2010 Jul;69(7):1378-1382.

van der Zee, P.; Biró, É.; Trouw, L.; Ko, Y.; de Winter, R.; , a. C.; Sturk, A.; Nieuwland, R. C-reactive protein in myocardial infarction binds to circulating microparticles but is not associated with complement activation. Cl. Immunol. 2010, 135 (3), 490-495.

van der Zee P, Biró É, Trouw L, et al. C-reactive protein in myocardial infarction binds to circulating microparticles but is not associated with complement activation. Cl Immunol. 2010;135(3):490-495.

P. van der Zee et al., “C-reactive protein in myocardial infarction binds to circulating microparticles but is not associated with complement activation,” Cl. Immunol., vol. 135, no. 3, pp. 490-495, June. 2010.

van der Zee P, Biró É, Trouw L, Ko Y, de Winter R, aC, et al. C-reactive protein in myocardial infarction binds to circulating microparticles but is not associated with complement activation. Cl Immunol. 2010 June;135(3):490-495.

Liebhardt, S.; Ditsch, N.; Nieuwland, R.; Rank, A.; Jeschke, U.; Von Koch, F.; Friese, K.; Toth, B. CEA-, Her2/neu-, BCRP-and Hsp27-positive microparticles in breast cancer patients. Anticancer Res. 2010, 30 (5), 1707-1712.

Liebhardt S, Ditsch N, Nieuwland R, et al. CEA-, Her2/neu-, BCRP-and Hsp27-positive microparticles in breast cancer patients. Anticancer Res. 2010;30(5):1707-1712.

S. Liebhardt et al., “CEA-, Her2/neu-, BCRP-and Hsp27-positive microparticles in breast cancer patients,” Anticancer Res., vol. 30, no. 5, pp. 1707-1712, May. 2010.

Liebhardt S, Ditsch N, Nieuwland R, Rank A, Jeschke U, Von Koch F, et al. CEA-, Her2/neu-, BCRP-and Hsp27-positive microparticles in breast cancer patients. Anticancer Res. 2010 May;30(5):1707-1712.

Nieuwland, R.; Sturk, A. Why do cells release vesicles?. Thromb. Res. 2010, 125 (Supplement 1), S49-S51.

Nieuwland R, Sturk A. Why do cells release vesicles?. Thromb Res. 2010;125(Supplement 1):S49-S51.

R. Nieuwland, and A. Sturk, “Why do cells release vesicles?,” Thromb. Res., vol. 125, no. Supplement 1, pp. S49-S51, Apr. 2010.

Nieuwland R, Sturk A. Why do cells release vesicles?. Thromb Res. 2010 Apr;125(Supplement 1):S49-S51.

Kleinjan, A.; , a. D. F.; Nieuwland, R. De rol van microvesikels in kanker. Ned. Tijdschr. Hematol. 2010, 7 (3), 99-106.

Kleinjan A, aDF, Nieuwland R. De rol van microvesikels in kanker. Ned Tijdschr Hematol. 2010;7(3):99-106.

A. Kleinjan, a. D. F. , and R. Nieuwland, “De rol van microvesikels in kanker,” Ned. Tijdschr. Hematol., vol. 7, no. 3, pp. 99-106, Mar. 2010.

Kleinjan A, aDF, Nieuwland R. De rol van microvesikels in kanker. Ned Tijdschr Hematol. 2010 Mar;7(3):99-106.

van der Pol, E.; Hoekstra, A. G.; Sturk, A.; Otto, C.; Van Leeuwen, T. G.; Nieuwland, R. Optical and non-optical methods for detection and characterization of microparticles and exosomes. J. Thromb. Haemost. 2010, 8 (12), 2596-2607.

van der Pol E, Hoekstra AG, Sturk A, Otto C, Van Leeuwen TG, Nieuwland R. Optical and non-optical methods for detection and characterization of microparticles and exosomes. J Thromb Haemost. 2010;8(12):2596-2607.

E. van der Pol, A. G. Hoekstra, A. Sturk, C. Otto, T. G. Van Leeuwen, and R. Nieuwland, “Optical and non-optical methods for detection and characterization of microparticles and exosomes,” J. Thromb. Haemost., vol. 8, no. 12, pp. 2596-2607, Dec. 2010.

van der Pol E, Hoekstra AG, Sturk A, Otto C, Van Leeuwen TG, Nieuwland R. Optical and non-optical methods for detection and characterization of microparticles and exosomes. J Thromb Haemost. 2010 Dec;8(12):2596-607.

Vedder, A. C.; Biró, É.; Aerts, J. M.; Nieuwland, R.; Sturk, G.; Hollak, C. E. Plasma markers of coagulation and endothelial activation in Fabry disease: impact of renal impairment. Nephrol. Dial. Transpl. 2009, 24 (10), 3074-3081.

Vedder AC, Biró É, Aerts JM, Nieuwland R, Sturk G, Hollak CE. Plasma markers of coagulation and endothelial activation in Fabry disease: impact of renal impairment. Nephrol Dial Transpl. 2009;24(10):3074-3081.

A. C. Vedder, É. Biró, J. M. Aerts, R. Nieuwland, G. Sturk, and C. E. Hollak, “Plasma markers of coagulation and endothelial activation in Fabry disease: impact of renal impairment,” Nephrol. Dial. Transpl., vol. 24, no. 10, pp. 3074-3081, Oct. 2009.

Vedder AC, Biró É, Aerts JM, Nieuwland R, Sturk G, Hollak CE. Plasma markers of coagulation and endothelial activation in Fabry disease: impact of renal impairment. Nephrol Dial Transpl. 2009 Oct;24(10):3074-3081.

Böing, A. N.; Hau, C.; Sturk, A.; Nieuwland, R. Human alternatively spliced tissue factor is not secreted and does not trigger coagulation. J. Thromb. Haemost. 2009, 7 (8), 1423-1426.

Böing AN, Hau C, Sturk A, Nieuwland R. Human alternatively spliced tissue factor is not secreted and does not trigger coagulation. J Thromb Haemost. 2009;7(8):1423-1426.

A. N. Böing, C. Hau, A. Sturk, and R. Nieuwland, “Human alternatively spliced tissue factor is not secreted and does not trigger coagulation,” J. Thromb. Haemost., vol. 7, no. 8, pp. 1423-1426, Aug. 2009.

Böing AN, Hau C, Sturk A, Nieuwland R. Human alternatively spliced tissue factor is not secreted and does not trigger coagulation. J Thromb Haemost. 2009 Aug;7(8):1423-1426.

Van Doormaal, F. F.; Kleinjan, A.; Di Nisio, M.; Büller, H. R.; Nieuwland, R. Cell-derived microvesicles and cancer. Neth. J. Med. 2009, 67 (7), 266-273.

Van Doormaal FF, Kleinjan A, Di Nisio M, Büller HR, Nieuwland R. Cell-derived microvesicles and cancer. Neth J Med. 2009;67(7):266-273.

F. F. Van Doormaal, A. Kleinjan, M. Di Nisio, H. R. Büller, and R. Nieuwland, “Cell-derived microvesicles and cancer,” Neth. J. Med., vol. 67, no. 7, pp. 266-273, Jul. 2009.

Van Doormaal FF, Kleinjan A, Di Nisio M, Büller HR, Nieuwland R. Cell-derived microvesicles and cancer. Neth J Med. 2009 Jul;67(7):266-273.

van Beers, E. J.; Schaap, M. C. L.; Berckmans, R. J.; Nieuwland, R.; Sturk, A.; van Doormaal, F. F.; Meijers, J. C. M.; Biemond, B. J. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica 2009, 94 (11), 1513-1519.

van Beers EJ, Schaap MCL, Berckmans RJ, et al. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica. 2009;94(11):1513-1519.

E. J. van Beers et al., “Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease,” Haematologica, vol. 94, no. 11, pp. 1513-1519, Jun. 2009.

van Beers EJ, Schaap MCL, Berckmans RJ, Nieuwland R, Sturk A, van Doormaal FF, et al. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica. 2009 Jun;94(11):1513-1519.

Reuwer, A. Q.; Nieuwland, R.; Fernandez, I.; Goffin, V.; van Tiel, C. M.; Schaap, M. C.; Berckmans, R. J.; Kastelein, J. J.; Twickler, M. T. Prolactin does not affect human platelet aggregation or secretion. Thromb. Haemostasis 2009, 101 (6), 1119-1127.

Reuwer AQ, Nieuwland R, Fernandez I, et al. Prolactin does not affect human platelet aggregation or secretion. Thromb Haemostasis. 2009;101(6):1119-1127.

A. Q. Reuwer et al., “Prolactin does not affect human platelet aggregation or secretion,” Thromb. Haemostasis, vol. 101, no. 6, pp. 1119-1127, Jun. 2009.

Reuwer AQ, Nieuwland R, Fernandez I, Goffin V, van Tiel CM, Schaap MC, et al. Prolactin does not affect human platelet aggregation or secretion. Thromb Haemostasis. 2009 Jun;101(6):1119-1127.

Lok, C. A. R.; Jebbink, J.; Nieuwland, R.; Faas, M. M.; Boer, K.; Sturk, A.; Van Der Post, J. A. M. Leukocyte activation and circulating leukocyte-derived microparticles in preeclampsia. Am. J. Reprod. Immunol. 2009, 61 (5), 346-359.

Lok CAR, Jebbink J, Nieuwland R, et al. Leukocyte activation and circulating leukocyte-derived microparticles in preeclampsia. Am J Reprod Immunol. 2009;61(5):346-359.

C. A. R. Lok et al., “Leukocyte activation and circulating leukocyte-derived microparticles in preeclampsia,” Am. J. Reprod. Immunol., vol. 61, no. 5, pp. 346-359, May. 2009.

Lok CAR, Jebbink J, Nieuwland R, Faas MM, Boer K, Sturk A, et al. Leukocyte activation and circulating leukocyte-derived microparticles in preeclampsia. Am J Reprod Immunol. 2009 May;61(5):346-359.

Papapanagiotou, D.; Nicu, E. A.; Bizzarro, S.; Gerdes, V. E. A.; Meijers, J. C.; Nieuwland, R.; van der Velden, U.; Loos, B. G. Periodontitis is associated with platelet activation. Atherosclerosis 2009, 202 (2), 605-611.

Papapanagiotou D, Nicu EA, Bizzarro S, et al. Periodontitis is associated with platelet activation. Atherosclerosis. 2009;202(2):605-611.

D. Papapanagiotou et al., “Periodontitis is associated with platelet activation,” Atherosclerosis, vol. 202, no. 2, pp. 605-611, Feb. 2009.

Papapanagiotou D, Nicu EA, Bizzarro S, Gerdes VEA, Meijers JC, Nieuwland R, et al. Periodontitis is associated with platelet activation. Atherosclerosis. 2009 Feb;202(2):605-611.

Nicu, E. A.; Van der Velden, U.; Nieuwland, R.; Everts, V.; Loos, B. G. Elevated platelet and leukocyte response to oral bacteria in periodontitis. J. Thromb. Haemost. 2009, 7 (1), 162-170.

Nicu EA, Van der Velden U, Nieuwland R, Everts V, Loos BG. Elevated platelet and leukocyte response to oral bacteria in periodontitis. J Thromb Haemost. 2009;7(1):162-170.

E. A. Nicu, U. Van der Velden, R. Nieuwland, V. Everts, and B. G. Loos, “Elevated platelet and leukocyte response to oral bacteria in periodontitis,” J. Thromb. Haemost., vol. 7, no. 1, pp. 162-170, Jan. 2009.

Nicu EA, Van der Velden U, Nieuwland R, Everts V, Loos BG. Elevated platelet and leukocyte response to oral bacteria in periodontitis. J Thromb Haemost. 2009 Jan;7(1):162-170.

Gerrits, A.; Koekman, C.; Yildirim, C.; Nieuwland, R.; Akkerman, J. Insulin inhibits tissue factor expression in monocytes. J. Thromb. Haemost. 2009, 7 (1), 198-205.

Gerrits A, Koekman C, Yildirim C, Nieuwland R, Akkerman J. Insulin inhibits tissue factor expression in monocytes. J Thromb Haemost. 2009;7(1):198-205.

A. Gerrits, C. Koekman, C. Yildirim, R. Nieuwland, and J. Akkerman, “Insulin inhibits tissue factor expression in monocytes,” J. Thromb. Haemost., vol. 7, no. 1, pp. 198-205, Jan. 2009.

Gerrits A, Koekman C, Yildirim C, Nieuwland R, Akkerman J. Insulin inhibits tissue factor expression in monocytes. J Thromb Haemost. 2009 Jan;7(1):198-205.

Lok, C. A. R.; Böing, A. N.; Sargent, I. L.; Sooranna, S. R.; van der Post, J. A. M.; Nieuwland, R.; Sturk, A. Circulating platelet-derived and placenta-derived microparticles expose Flt-1 in preeclampsia. Reprod. Sci. 2008, 15 (10), 1002-1010.

Lok CAR, Böing AN, Sargent IL, et al. Circulating platelet-derived and placenta-derived microparticles expose Flt-1 in preeclampsia. Reprod Sci. 2008;15(10):1002-1010.

C. A. R. Lok et al., “Circulating platelet-derived and placenta-derived microparticles expose Flt-1 in preeclampsia,” Reprod. Sci., vol. 15, no. 10, pp. 1002-1010, Dec. 2008.

Lok CAR, Böing AN, Sargent IL, Sooranna SR, van der Post JAM, Nieuwland R, et al. Circulating platelet-derived and placenta-derived microparticles expose Flt-1 in preeclampsia. Reprod Sci. 2008 Dec;15(10):1002-1010.

Buimer, M.; Lok, C.; Nieuwland, R.; Ris-Stalpers, C.; van der Post, J. Placental corticotrophin?releasing hormone mRNA and microparticles in maternal plasma are not measures of placental shedding of debris: a rebuttal. J. Thromb. Haemost. 2008, 6 (10), 1837-1838.

Buimer M, Lok C, Nieuwland R, Ris-Stalpers C, van der Post J. Placental corticotrophin?releasing hormone mRNA and microparticles in maternal plasma are not measures of placental shedding of debris: a rebuttal. J Thromb Haemost. 2008;6(10):1837-1838.

M. Buimer, C. Lok, R. Nieuwland, C. Ris-Stalpers, and J. van der Post, “Placental corticotrophin?releasing hormone mRNA and microparticles in maternal plasma are not measures of placental shedding of debris: a rebuttal,” J. Thromb. Haemost., vol. 6, no. 10, pp. 1837-1838, Oct. 2008.

Buimer M, Lok C, Nieuwland R, Ris-Stalpers C, van der Post J. Placental corticotrophin?releasing hormone mRNA and microparticles in maternal plasma are not measures of placental shedding of debris: a rebuttal. J Thromb Haemost. 2008 Oct;6(10):1837-1838.

van den Goor, J. M.; Saxby, B.; Tijssen, J.; Wesnes, K.; de Mol, B.; Nieuwland, R. Improvement of cognitive test performance in patients undergoing primary CABG and other CPB-assisted cardiac procedures. Perfusion 2008, 23 (5), 267-273.

van den Goor JM, Saxby B, Tijssen J, Wesnes K, de Mol B, Nieuwland R. Improvement of cognitive test performance in patients undergoing primary CABG and other CPB-assisted cardiac procedures. Perfusion. 2008;23(5):267-273.

J. M. van den Goor, B. Saxby, J. Tijssen, K. Wesnes, B. de Mol, and R. Nieuwland, “Improvement of cognitive test performance in patients undergoing primary CABG and other CPB-assisted cardiac procedures,” Perfusion, vol. 23, no. 5, pp. 267-273, Sep. 2008.

van den Goor JM, Saxby B, Tijssen J, Wesnes K, de Mol B, Nieuwland R. Improvement of cognitive test performance in patients undergoing primary CABG and other CPB-assisted cardiac procedures. Perfusion. 2008 Sep;23(5):267-273.

Nieuwland, R. Cellular origin of microparticles exposing tissue factor in cancer: a mixed double?. J. Thromb. Haemost. 2008, 6 (9), 1514-1516.

Nieuwland R. Cellular origin of microparticles exposing tissue factor in cancer: a mixed double?. J Thromb Haemost. 2008;6(9):1514-1516.

R. Nieuwland, “Cellular origin of microparticles exposing tissue factor in cancer: a mixed double?,” J. Thromb. Haemost., vol. 6, no. 9, pp. 1514-1516, Sep. 2008.

Nieuwland R. Cellular origin of microparticles exposing tissue factor in cancer: a mixed double?. J Thromb Haemost. 2008 Sep;6(9):1514-1516.

Diamant, M.; Tushuizen, M. E.; Abid-Hussein, M. N.; Hau, C. M.; Böing, A. N.; Sturk, A.; Nieuwland, R. Simvastatin-induced endothelial cell detachment and microparticle release are prenylation dependent. Thromb. Haemostasis 2008, 100 (09), 489-497.

Diamant M, Tushuizen ME, Abid-Hussein MN, et al. Simvastatin-induced endothelial cell detachment and microparticle release are prenylation dependent. Thromb Haemostasis. 2008;100(09):489-497.

M. Diamant et al., “Simvastatin-induced endothelial cell detachment and microparticle release are prenylation dependent,” Thromb. Haemostasis, vol. 100, no. 09, pp. 489-497, Sep. 2008.

Diamant M, Tushuizen ME, Abid-Hussein MN, Hau CM, Böing AN, Sturk A, et al. Simvastatin-induced endothelial cell detachment and microparticle release are prenylation dependent. Thromb Haemostasis. 2008 Sep;100(09):489-497.

Abid Hussein, M. N.; Böing, A. N.; Biró, É.; Hoek, F. J.; Vogel, G. M. T.; Meuleman, D. G.; Sturk, A.; Nieuwland, R. Phospholipid composition of in vitro endothelial microparticles and their in vivo thrombogenic properties. Thromb. Res. 2008, 121 (6), 865-871.

Abid Hussein MN, Böing AN, Biró É, et al. Phospholipid composition of in vitro endothelial microparticles and their in vivo thrombogenic properties. Thromb Res. 2008;121(6):865-871.

M. N. Abid Hussein et al., “Phospholipid composition of in vitro endothelial microparticles and their in vivo thrombogenic properties,” Thromb. Res., vol. 121, no. 6, pp. 865-871, Jun. 2008.

Abid Hussein MN, Böing AN, Biró É, Hoek FJ, Vogel GMT, Meuleman DG, et al. Phospholipid composition of in vitro endothelial microparticles and their in vivo thrombogenic properties. Thromb Res. 2008 Jun;121(6):865-871.

Lok, C. A. R.; Van Der Post, J. A. M.; Sargent, I. L.; Hau, C. M.; Sturk, A.; Boer, K.; Nieuwland, R. Changes in microparticle numbers and cellular origin during pregnancy and preeclampsia. Hypertens. Pregnancy 2008, 27 (4), 344-360.

Lok CAR, Van Der Post JAM, Sargent IL, et al. Changes in microparticle numbers and cellular origin during pregnancy and preeclampsia. Hypertens Pregnancy. 2008;27(4):344-360.

C. A. R. Lok et al., “Changes in microparticle numbers and cellular origin during pregnancy and preeclampsia,” Hypertens. Pregnancy, vol. 27, no. 4, pp. 344-360, Apr. 2008.

Lok CAR, Van Der Post JAM, Sargent IL, Hau CM, Sturk A, Boer K, et al. Changes in microparticle numbers and cellular origin during pregnancy and preeclampsia. Hypertens Pregnancy. 2008 Apr;27(4):344-360.

Toth, B.; Nieuwland, R.; Liebhardt, S.; Ditsch, N.; Steinig, K.; Stieber, P.; Rank, A.; Goehring, P.; Thaler, C. J.; Friese, K.; et al. Circulating microparticles in breast cancer patients: a comparative analysis with established biomarkers. Anticancer Res. 2008, 28 (2A), 1107-1112.

Toth B, Nieuwland R, Liebhardt S, et al. Circulating microparticles in breast cancer patients: a comparative analysis with established biomarkers. Anticancer Res. 2008;28(2A):1107-1112.

B. Toth et al., “Circulating microparticles in breast cancer patients: a comparative analysis with established biomarkers,” Anticancer Res., vol. 28, no. 2A, pp. 1107-1112, Mar-Apr. 2008.

Toth B, Nieuwland R, Liebhardt S, Ditsch N, Steinig K, Stieber P, et al. Circulating microparticles in breast cancer patients: a comparative analysis with established biomarkers. Anticancer Res. 2008 Mar-Apr;28(2A):1107-1112.

Böing, A. N.; Hau, C. M.; Sturk, A.; Nieuwland, R. Platelet microparticles contain active caspase 3. Platelets 2008, 19 (2), 96-103.

Böing AN, Hau CM, Sturk A, Nieuwland R. Platelet microparticles contain active caspase 3. Platelets. 2008;19(2):96-103.

A. N. Böing, C. M. Hau, A. Sturk, and R. Nieuwland, “Platelet microparticles contain active caspase 3,” Platelets, vol. 19, no. 2, pp. 96-103, Mar. 2008.

Böing AN, Hau CM, Sturk A, Nieuwland R. Platelet microparticles contain active caspase 3. Platelets. 2008 Mar;19(2):96-103.

Toth, B.; Nieuwland, R.; Kern, M.; Rogenhofer, N.; Berckmans, R.; Rank, A.; Lohse, P.; Friese, K.; Thaler, C. J. Systemic changes in haemostatic balance are not associated with increased levels of circulating microparticles in women with recurrent spontaneous abortion. Am. J. Reprod. Immunol. 2008, 59 (2), 159-166.

Toth B, Nieuwland R, Kern M, et al. Systemic changes in haemostatic balance are not associated with increased levels of circulating microparticles in women with recurrent spontaneous abortion. Am J Reprod Immunol. 2008;59(2):159-166.

B. Toth et al., “Systemic changes in haemostatic balance are not associated with increased levels of circulating microparticles in women with recurrent spontaneous abortion,” Am. J. Reprod. Immunol., vol. 59, no. 2, pp. 159-166, Feb. 2008.

Toth B, Nieuwland R, Kern M, Rogenhofer N, Berckmans R, Rank A, et al. Systemic changes in haemostatic balance are not associated with increased levels of circulating microparticles in women with recurrent spontaneous abortion. Am J Reprod Immunol. 2008 Feb;59(2):159-166.

Toth, B.; Lok, C. A. R.; Böing, A.; Diamant, M.; Van Der Post, J. A. M.; Friese, K.; Nieuwland, R. Microparticles and exosomes: impact on normal and complicated pregnancy. Am. J. Reprod. Immunol. 2007, 58 (5), 389-402.

Toth B, Lok CAR, Böing A, et al. Microparticles and exosomes: impact on normal and complicated pregnancy. Am J Reprod Immunol. 2007;58(5):389-402.

B. Toth et al., “Microparticles and exosomes: impact on normal and complicated pregnancy,” Am. J. Reprod. Immunol., vol. 58, no. 5, pp. 389-402, Nov. 2007.

Toth B, Lok CAR, Böing A, Diamant M, Van Der Post JAM, Friese K, et al. Microparticles and exosomes: impact on normal and complicated pregnancy. Am J Reprod Immunol. 2007 Nov;58(5):389-402.

Toth, B.; Nikolajek, K.; Rank, A.; Nieuwland, R.; Lohse, P.; Pihusch, V.; Friese, K.; Thaler, C. J. Gender-specific and menstrual cycle dependent differences in circulating microparticles. Platelets 2007, 18 (7), 515-521.

Toth B, Nikolajek K, Rank A, et al. Gender-specific and menstrual cycle dependent differences in circulating microparticles. Platelets. 2007;18(7):515-521.

B. Toth et al., “Gender-specific and menstrual cycle dependent differences in circulating microparticles,” Platelets, vol. 18, no. 7, pp. 515-521, Nov. 2007.

Toth B, Nikolajek K, Rank A, Nieuwland R, Lohse P, Pihusch V, et al. Gender-specific and menstrual cycle dependent differences in circulating microparticles. Platelets. 2007 Nov;18(7):515-521.

Abid Hussein, M. N.; Böing, A. N.; Sturk, A.; Hau, C. M.; Nieuwland, R. Inhibition of microparticle release triggers endothelial cell apoptosis and detachment. Thromb. Haemostasis 2007, 98 (11), 1096-1107.

Abid Hussein MN, Böing AN, Sturk A, Hau CM, Nieuwland R. Inhibition of microparticle release triggers endothelial cell apoptosis and detachment. Thromb Haemostasis. 2007;98(11):1096-1107.

M. N. Abid Hussein, A. N. Böing, A. Sturk, C. M. Hau, and R. Nieuwland, “Inhibition of microparticle release triggers endothelial cell apoptosis and detachment,” Thromb. Haemostasis, vol. 98, no. 11, pp. 1096-1107, Nov. 2007.

Abid Hussein MN, Böing AN, Sturk A, Hau CM, Nieuwland R. Inhibition of microparticle release triggers endothelial cell apoptosis and detachment. Thromb Haemostasis. 2007 Nov;98(11):1096-1107.

van den Goor, J. M.; Nieuwland, R.; van Oeveren, W.; Rutten, P. M.; Tijssen, J. G.; Hau, C. M.; Sturk, A.; Eijsman, L.; de Mol, B. A. Cell saver device efficiently removes cell-derived microparticles during cardiac surgery. J. Thorac. Cardiov. Sur. 2007, 134 (3), 798-799.

van den Goor JM, Nieuwland R, van Oeveren W, et al. Cell saver device efficiently removes cell-derived microparticles during cardiac surgery. J Thorac Cardiov Sur. 2007;134(3):798-799.

J. M. van den Goor et al., “Cell saver device efficiently removes cell-derived microparticles during cardiac surgery,” J. Thorac. Cardiov. Sur., vol. 134, no. 3, pp. 798-799, Sep. 2007.

van den Goor JM, Nieuwland R, van Oeveren W, Rutten PM, Tijssen JG, Hau CM, et al. Cell saver device efficiently removes cell-derived microparticles during cardiac surgery. J Thorac Cardiov Sur. 2007 Sep;134(3):798-799.

Biró, É.; Lok, C. A. R.; Hack, C. E.; Van der Post, J. A. M.; Schaap, M. C. L.; Sturk, A.; Nieuwland, R. Cell-derived microparticles and complement activation in preeclampsia versus normal pregnancy. Placenta 2007, 28 (8-9), 928-935.

Biró É, Lok CAR, Hack CE, et al. Cell-derived microparticles and complement activation in preeclampsia versus normal pregnancy. Placenta. 2007;28(8-9):928-935.

É. Biró et al., “Cell-derived microparticles and complement activation in preeclampsia versus normal pregnancy,” Placenta, vol. 28, no. 8-9, pp. 928-935, Aug-Sep. 2007.

Biró É, Lok CAR, Hack CE, Van der Post JAM, Schaap MCL, Sturk A, et al. Cell-derived microparticles and complement activation in preeclampsia versus normal pregnancy. Placenta. 2007 Aug-Sep;28(8-9):928-935.

Biró, É.; Nieuwland, R.; Tak, P. P.; Pronk, L. M.; Schaap, M. C. L.; Sturk, A.; Hack, C. E. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals. Ann. Rheum. Dis. 2007, 66 (8), 1085-1092.

Biró É, Nieuwland R, Tak PP, et al. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals. Ann Rheum Dis. 2007;66(8):1085-1092.

É. Biró et al., “Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals,” Ann. Rheum. Dis., vol. 66, no. 8, pp. 1085-1092, Aug. 2007.

Biró É, Nieuwland R, Tak PP, Pronk LM, Schaap MCL, Sturk A, et al. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals. Ann Rheum Dis. 2007 Aug;66(8):1085-1092.

van den Goor, J. M.; Nieuwland, R.; Rutten, P. M.; Tijssen, J. G.; Hau, C.; Sturk, A.; Eijsman, L.; de Mol, B. A. Retransfusion of pericardial blood does not trigger systemic coagulation during cardiopulmonary bypass. Eur. J. Cardio-thorac. 2007, 31 (6), 1029-1036.

van den Goor JM, Nieuwland R, Rutten PM, et al. Retransfusion of pericardial blood does not trigger systemic coagulation during cardiopulmonary bypass. Eur J Cardio-thorac. 2007;31(6):1029-1036.

J. M. van den Goor et al., “Retransfusion of pericardial blood does not trigger systemic coagulation during cardiopulmonary bypass,” Eur. J. Cardio-thorac., vol. 31, no. 6, pp. 1029-1036, Jun. 2007.

van den Goor JM, Nieuwland R, Rutten PM, Tijssen JG, Hau C, Sturk A, et al. Retransfusion of pericardial blood does not trigger systemic coagulation during cardiopulmonary bypass. Eur J Cardio-thorac. 2007 Jun;31(6):1029-1036.

Tushuizen, M. E.; Nieuwland, R.; Rustemeijer, C.; Hensgens, B. E.; Sturk, A.; Heine, R. J.; Diamant, M. Elevated endothelial microparticles following consecutive meals are associated with vascular endothelial dysfunction in type 2 diabetes. Diabetes Care 2007, 30 (3), 728-730.

Tushuizen ME, Nieuwland R, Rustemeijer C, et al. Elevated endothelial microparticles following consecutive meals are associated with vascular endothelial dysfunction in type 2 diabetes. Diabetes Care. 2007;30(3):728-730.

M. E. Tushuizen et al., “Elevated endothelial microparticles following consecutive meals are associated with vascular endothelial dysfunction in type 2 diabetes,” Diabetes Care, vol. 30, no. 3, pp. 728-730, Mar. 2007.

Tushuizen ME, Nieuwland R, Rustemeijer C, Hensgens BE, Sturk A, Heine RJ, et al. Elevated endothelial microparticles following consecutive meals are associated with vascular endothelial dysfunction in type 2 diabetes. Diabetes Care. 2007 Mar;30(3):728-730.

Lok, C. A. R.; Nieuwland, R.; Sturk, A.; Hau, C. M.; Boer, K.; Vanbavel, E.; Vanderpost, J. A. M. Microparticle-associated P-selectin reflects platelet activation in preeclampsia. Platelets 2007, 18 (1), 68-72.

Lok CAR, Nieuwland R, Sturk A, et al. Microparticle-associated P-selectin reflects platelet activation in preeclampsia. Platelets. 2007;18(1):68-72.

C. A. R. Lok et al., “Microparticle-associated P-selectin reflects platelet activation in preeclampsia,” Platelets, vol. 18, no. 1, pp. 68-72, Feb. 2007.

Lok CAR, Nieuwland R, Sturk A, Hau CM, Boer K, Vanbavel E, et al. Microparticle-associated P-selectin reflects platelet activation in preeclampsia. Platelets. 2007 Feb;18(1):68-72.